title: Budget Impact Analysis of Introducing Biosimilar Infliximab for the Treatment of Auto Immune Disorders In Five European Countries.
authors.affiliation: Mundipharma International Limited, Cambridge, UK.
authors.forename: A
authors.initials: A
authors.lastname: Jha
authors.affiliation: Abacus International, Bicester, UK.
authors.forename: A
authors.initials: A
authors.lastname: Upton
authors.affiliation: Mundipharma International Limited, Cambridge, UK.
authors.forename: W
authors.initials: W
authors.lastname: Dunlop